Sight Sciences (SGHT) Other Non-Current Liabilities (2020 - 2026)
Sight Sciences' (SGHT) quarterly Other Non-Current Liabilities came in at $900000.0 in Q1 2026, up 159.37% year-on-year from $347000.0 in Q1 2025, and up 2803.23% quarter-over-quarter from $31000.0 in Q4 2025.
Sight Sciences (SGHT) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Sight Sciences' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $900000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 159.37% year-over-year to $900000.0 in Q1 2026; TTM through Mar 2026 was $900000.0, a 159.37% increase from a year earlier, with the FY2025 full-year figure at $31000.0, down 93.7% from the prior year.
- Other Non-Current Liabilities grew to $900000.0 in Q1 2026 per SGHT's latest filing, from $31000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.5 million in Q4 2023 and bottomed at $19000.0 in Q3 2025.
- The 5-year median for Other Non-Current Liabilities is $347000.0 (2025), against an average of $688882.4.
- Across the five-year window, Other Non-Current Liabilities sank 98.02% in 2022 and jumped 6415.79% in 2023, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $38000.0 in 2022, then soared by 6415.79% to $2.5 million in 2023, then plunged by 80.13% to $492000.0 in 2024, then plunged by 93.7% to $31000.0 in 2025, then soared by 2803.23% to $900000.0 in 2026.
- Per Business Quant, the three latest SGHT Other Non-Current Liabilities figures stand at $900000.0 (Q1 2026), $31000.0 (Q4 2025), and $19000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Sight Sciences | 276.70 Mn | 191.73 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 202,000.00 |
| Mar 31, 2025 | 347,000.00 |
| Dec 31, 2024 | 492,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 961,000.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 39,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 1.92 Mn |
| Sep 30, 2021 | 345,000.00 |
| Jun 30, 2021 | 8.11 Mn |